Filter
1264
Filtered Results: 1264
Text search:
viral
load
testing
Featured
Recommendations
138
New Publications
377
Language
Document type
No document type
813
Guidelines
198
Studies & Reports
143
Manuals
45
Fact sheets
23
Strategic & Response Plan
15
Training Material
12
Infographics
9
Situation Updates
4
Resource Platforms
2
Countries / Regions
India
88
South Africa
49
Kenya
37
Tanzania
32
Uganda
32
Zambia
29
Nigeria
27
Ethiopia
27
Malawi
26
Global
26
Sierra Leone
19
Africa
19
Nepal
18
Lesotho
18
Rwanda
18
Liberia
17
Western and Central Europe
16
Namibia
15
Ghana
14
Myanmar / Burma
14
Asia
13
Bangladesh
13
Zimbabwe
12
Russia
11
Ukraine
10
Philippines
8
Mozambique
8
Germany
8
Eastern Europe
8
Albania
7
Latin America and the Carribbean
7
Brazil
7
Congo, Democratic Republic of
6
East and Southern Africa
6
Indonesia
6
Eswatini/ Swaziland
6
Tajikistan
5
Cambodia
5
South–East Asia Region
5
Vietnam
5
Georgia
5
Botswana
5
Peru
4
Guinea
4
Armenia
4
West and Central Africa
4
Eastern Europe and Central Asia
4
North Macedonia
3
Senegal
3
Burkina Faso
3
Venezuela
3
Middle East and North Africa
3
Angola
3
Cameroon
2
Syria
2
Portugal
2
Moldova
2
Somalia
2
Madagascar
2
Colombia
1
Thailand
1
Turkey
1
Chile
1
Laos
1
Estonia
1
Hungary
1
Jordan
1
North America
1
Belgium
1
France
1
United Kingdom
1
Spain
1
Belarus
1
Latvia
1
Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Bolivia
1
Argentina
1
Yemen
1
Central African Republic
1
Poland
1
Mali
1
Bhutan
1
South Sudan
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
518
Clinical Guidelines
111
Women & Child Health
33
Public Health
31
Key Resources
28
Pharmacy & Technologies
21
Capacity Building
19
Toolboxes
HIV
409
COVID-19
108
TB
64
Ebola
40
Rapid Response
31
AMR
18
Pharmacy
15
Caregiver
13
NTDs
12
NCDs
12
Zika
12
Refugee
11
Planetary Health
9
Mental Health
8
Specific Hazards
4
Conflict
4
Polio
4
Natural Hazards
3
Global Health Education
2
Disability
1
Cholera
1
Health Financing Toolbox
1
The Bolivarian Republic of Venezuela has been facing a sociopolitical and economic situation that has negatively impacted social and health indicators. There have been intensified population movements both within the country and to other countries, particularly to Argentina, Brazil, Chile, Colombia,...
However, very little is known about the trend of the quality of life over
time in untreated PLWHA compared to treated patients.
Exploring quality of life trends in treated and untreated
patients will help the health care system develop adapted
strategies to better manage the PLWHA in low-income
...
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
fir...
In line with its decentralization principle, the Ethiopian Health Policy has achieved great progress in improving access to comprehensive HIV/AIDS services to the majority of the population. Both quality and coverage of services have improved significantlysince the initiation...
nterim guidance, first issued 25 January 2021, updated 15 June 2021, updated 19 November 2021, updated 23 February 2022, updated 18 August 2022
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenc...
The key areas covered are diagnosis, imaging, pathology, surgery, rehabilitation, palliative care and survivorship. It emphasizes a multi-disciplinary team approach which is paramount for quality cancer care. The specific cancers covered are breast, central nervous system, gastroint...
25 February 2021
This technical guidance is a living document that builds on guidelines and reports of the UNAIDS Joint Programme. The definitions contained herein are working definitions that are subject to change. Updates will also be added further to the work of the multistakeholder Task Team on...
6 June 2022
These WHO interim recommendations on the use of the Janssen Ad26.COV2.S (COVID-19) vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
Th...
The new Global AIDS Strategy 2021--2026, End Inequalities, End AIDS, is a bold approach that uses an inequalities lens to close the gaps preventing progress to end AIDS
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
These WHO interim recommendations for use of the Sinovac-CoronaVac were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been updat...
2nd edition, June 2021
This first edition of our national neonatal care clinical guidelines is an initiative that aims to ensure that all the neonates in the Kingdom of Eswatini are offered standard, best quality of care and the best possible start in life. The guidelines have been formulated from various global sources a...
These WHO interim recommendations for use of the COVID-19 vaccine BIBP produced by Sinopharm were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Th...
Updated Treatment Guidelines
Kenya Quality Model for Health - Level 2 Facilities
Kenya Quality Model for Health - Health Facilities
an approach to optimize the global impact of COVID-19 vaccines, based on public health goals, global and national equity, and vaccine access and coverage scenarios, first issued 20 October 2020, updated: 13 November 2020, updated: 16 July 2021, latest update: 21 January 2022
Available in English, F...
N Engl J Med 2022; 386:911-922, DOI: 10.1056/NEJMoa2104535
Four months of antituberculosis treatment was noninferior to 6 months of treatment in children with drug-susceptible, nonsevere, smear-negative tuberculosis (SHINE Study)
